← Product Code [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS) · K955642

# NELLCOR SYMPHONY N-3000 PATIENT MONITOR W/SP02 & ECG/N-3200 DISPLAY/PRINTER (K955642)

_Nellcor Puritan Bennett, Inc. · DPS · Jul 2, 1996 · Cardiovascular · SESE_

**Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K955642

## Device Facts

- **Applicant:** Nellcor Puritan Bennett, Inc.
- **Product Code:** [DPS](/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS.md)
- **Decision Date:** Jul 2, 1996
- **Decision:** SESE
- **Submission Type:** Traditional
- **Regulation:** 21 CFR 870.2340
- **Device Class:** Class 2
- **Review Panel:** Cardiovascular
- **Attributes:** Pediatric

## Indications for Use

The purpose and function of the N-3000E Patient Monitor is to: - noninvasively and continuously monitor functional arterial oxygen saturation and pulse rate (using an accessory SpO2 sensor); - noninvasively and continuously monitor ECG and heart rate (using accessory ECG leads). When connected to the N-3200 Display/Printer, the purpose and function of the combined device is expanded to: - display and print out associated ECG and Plethysmographic waveforms, SpO2, pulse rate and heart rate. When further connected to the N-3100 Blood Pressure Monitor, the intended use of the interconnected N-3000E/N-3100/N-3200 is also to: - noninvasively and automatically measure systolic, diastolic and mean arterial blood pressure and to derive pulse rate from these measurements (using accessory blood pressure cuffs); and display and print out systolic, diastolic and mean arterial blood pressure (on the N-3200 display/printer) When the N-3100 is connected to the N-3200 Display/Printer, the purpose and function of the combined device (compared to K945947) is expanded to: - display and print out associated pulse rate and systolic, diastolic and mean arterial blood pressure. The N-3000E Patient Monitor is intended for use in hospital, hospital-type and hospital transport environments as a "standalone" product and when connected to the N-3200 display/printer and/or the N-3100 blood pressure monitor. It is also intended for use to monitor neonatal, pediatric, or adult patients. The N-3000E, N-3200 and N-3100 are for prescription use only.

## Device Story

N-3000E Patient Monitor system; monitors SpO2, pulse rate, ECG, heart rate, and NIBP (when connected to N-3100). Inputs: surface ECG electrodes, SpO2 sensor, NIBP cuff. Processing: ECG signal amplification, noise filtering, and QRS detection algorithm; SpO2 processing via established Nellcor algorithm. Outputs: numerical heart rate, SpO2, blood pressure; graphical waveforms via N-3200 Display/Printer. Used in hospital/transport settings by clinicians. Benefits: continuous physiological monitoring for patient status assessment and clinical decision-making.

## Clinical Evidence

Bench testing only. Compliance with AAMI/ANSI EC-13 standard (except clause 3.2.6.1) for ECG module. Verification testing confirmed that adding ECG and display/printer functionality did not adversely affect the safety or effectiveness of the predicate pulse oximetry and NIBP functions.

## Technological Characteristics

ECG module: 3-lead surface electrodes, amplification, noise filtering. SpO2/NIBP: identical to predicate N-3000/N-3100. Connectivity: modular interconnection between N-3000E, N-3100, and N-3200. Standards: AAMI/ANSI EC-13 (except 3.2.6.1).

## Regulatory Identification

An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.

## Predicate Devices

- Datascope PASSPORT
- Protocol Systems PROPAQ 104
- NELLCOR SYMPHONY N-3000 Pulse Oximeter
- NELLCOR SYMPHONY N-3100 Blood Pressure Monitor

## Submission Summary (Full Text)

> This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com.
>
> Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/).

{0}

K955642

# ATTACHMENT 7

JUL 2 1998

# 510(k) SUMMARY, REVISED

## (f) Intended Use:

The purpose and function of the N-3000E Patient Monitor is to:

- noninvasively and continuously monitor functional arterial oxygen saturation and pulse rate (using an accessory $\mathrm{SpO}_2$ sensor);
- noninvasively and continuously monitor ECG and heart rate (using accessory ECG leads).

When connected to the N-3200 Display/Printer, the purpose and function of the combined device is expanded to:

- display and print out associated ECG and Plethysmographic waveforms, SpO2, pulse rate and heart rate.

When further connected to the N-3100 Blood Pressure Monitor, the intended use of the interconnected N-3000E/N-3100/N-3200 is also to:

- noninvasively and automatically measure systolic, diastolic and mean arterial blood pressure and to derive pulse rate from these measurements (using accessory blood pressure cuffs); and display and print out systolic, diastolic and mean arterial blood pressure (on the N-3200 display/printer)

When the N-3100 is connected to the N-3200 Display/Printer, the purpose and function of the combined device (compared to K945947) is expanded to:

- display and print out associated pulse rate and systolic, diastolic and mean arterial blood pressure.

The N-3000E Patient Monitor is intended for use in hospital, hospital-type and hospital transport environments as a "standalone" product and when connected to the N-3200 display/printer and/or the N-3100 blood pressure monitor. It is also intended for use to monitor neonatal, pediatric, or adult patients. The N-3000E, N-3200 and N-3100 are for prescription use only.

The N-3000E, the N-3000E connected to the N-3200, the N-3000E connected to the N-3100 and the N-3000E connected to both the N-3200 and N-3100 have the following similar intended uses to the predicate devices, in terms of function/purpose, environment of use and patient population:

Datascope PASSPORT - pulse oximetry, ECG, NIBP, display/printing functions; hospital and hospital-type environments; adult/pediatric patients

Protocol Systems PROPAQ 104 - pulse oximetry, ECG, NIBP, display/printing functions; hospital, hospital-type, environments; adult/pediatric patients

NELLCOR SYMPHONY™ N-3000 Pulse Oximeter - pulse oximetry function; hospital, hospital-type; adult/pediatric/neonate patients

{1}

NELLCOR SYMPHONY™ N-3100 Blood Pressure Monitor, standalone and in combination with the NELLCOR SYMPHONY™ N-3000 Pulse Oximeter; pulse oximetry, NIBP functions; hospital, hospital-type environments; adult/pediatric/neonate patients.

The N-3000E, N-3200 and N-3100 differ from the Datascope PASSPORT and Protocol Systems PROPAQ 104 in having fewer measurement/monitoring parameters available. They also differ in that they include neonates in their intended patient population but do not include home or mobile environments.

The N-3000E/N-3200/N-3100 devices have the same patient population as the predicate N-3000 pulse oximeter and predicate N-3100 blood pressure monitor, including adult, pediatric and neonate patients. They differ only in that they feature ECG as an additional measurement parameter and include a display/printer function, but do not include home or mobile environments.

(g) Technological Characteristics

Intrinsic electrocardiac signals are collected by conventional patient surface electrodes and conducted via a 3-lead ECG lead set and cable to the N-3000E's ECG processing module. These signals then undergo amplification and noise filtering. A software algorithm operates on the processed ECG signal to identify sequential QRS complexes and, hence, determine heart rate for numerical presentation on the N-3000E's front panel display. The processed ECG signal may also be supplied to the N-3200 Display/Printer for graphical presentation and printout. The ECG module is designed to comply with the AAMI/ANSI EC-13 standard, with the exception of clause 3.2.6.1. Test results confirming compliance with this standard have been included in the 510(k) submission.

The technological characteristics of the pulse oximetry function of the N-3000E are identical to those in the predicate N-3000 pulse oximeter. The same algorithm is used in both products. Testing has been conducted to confirm that modification of the N-3000 pulse oximeter to add an ECG function and access to the N-3200 display/printer have not affected the safety or effectiveness of the oximetry function of the N-3000E.

Safety and effectiveness of the N-3000E, alone and in combination with the N-3200 display/printer and/or the N-3100 blood pressure monitor, have been confirmed by complying with the requirements of the Reviewer Guidance for Premarket Notification Submissions, November 1993, through design, testing and labeling.

---

**Source:** [https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K955642](https://fda.innolitics.com/submissions/CV/subpart-c%E2%80%94cardiovascular-monitoring-devices/DPS/K955642)

**Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact).

**Cite:** Innolitics at https://innolitics.com
